Literature DB >> 6208785

The immunohistology of the thymus in myasthenia gravis.

M J Kornstein, J J Brooks, A O Anderson, A I Levinson, R P Lisak, B Zweiman.   

Abstract

We have investigated cell subpopulations in frozen sections of thymus tissue obtained from myasthenic (MG) and control subjects. With the use of an avidin-biotin immunoperoxidase system with monoclonal antibodies, the following cell surface antigens were studied on frozen sections (12 MG and 3 control thymus); T11, T4, T6, T8, IgM, IgD, and Ia. The pattern of T cell phenotypes in MG thymus is similar to that of normal control thymus when examined by immunohistologic techniques. MG cortical thymocytes are virtually all T11+, T4+, T8+, and T6+. In the medulla, at least 45% of thymocytes are T11+, with T4+ cells predominating over T8+ cells. Approximately 10% of medullary thymocytes are T6+. Scattered medullary cells expressing surface IgM and IgD are identified in both MG and normal thymuses. However, unlike the normal thymus, the MG thymus has numerous secondary follicles containing IgM- and IgD-bearing cells. This finding supports the hypothesis that the MG thymus microenvironment is aberrant. The Ia antigen is found in similar tissue section localization patterns in MG and control thymus. Ultramicroscopic studies show the Ia antigen predominantly on epithelial and interdigitating dendritic cells. By immunoperoxidase techniques, numerous keratin-positive cells are demonstrated in MG and control thymus. This suggests that thymic epithelial cells, like epithelial cells elsewhere, contain keratin. Because these data differ in degree from our previous findings in suspensions of MG thymocytes, this study emphasizes the importance of examining tissue sections as well as cell suspensions when one is studying lymphocyte surface markers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208785      PMCID: PMC1900444     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The human thymic microenvironment: an immunohistologic study.

Authors:  G Janossy; J A Thomas; F J Bollum; S Granger; G Pizzolo; K F Bradstock; L Wong; A McMichael; K Ganeshaguru; A V Hoffbrand
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

2.  Cells bearing Ia antigens in the murine thymus. An ultrastructural study.

Authors:  A G Farr; P K Nakane
Journal:  Am J Pathol       Date:  1983-04       Impact factor: 4.307

3.  Delineation of human thymocyte differentiation pathways utilizing double-staining techniques with monoclonal antibodies.

Authors:  N Tidman; G Janossy; M Bodger; S Granger; P C Kung; G Goldstein
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

4.  Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses.

Authors:  J A Thomas; H N Willcox; J Newsom-Davis
Journal:  J Neuroimmunol       Date:  1982-12       Impact factor: 3.478

5.  S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells.

Authors:  T Nakajima; S Watanabe; Y Sato; Y Shimosato; M Motoi; K Lennert
Journal:  Gan       Date:  1982-06

6.  Distribution of H-2 microenvironments in the mouse thymus. Immunoelectron microscopic identification of I-A and H-2K bearing cells.

Authors:  W Van Ewijk; R V Rouse; I L Weissman
Journal:  J Histochem Cytochem       Date:  1980-10       Impact factor: 2.479

7.  Distribution of t lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies.

Authors:  G Janossy; N Tidman; E S Papageorgiou; P C Kung; G Goldstein
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

8.  Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.

Authors:  J Newsom-Davis; N Willcox; L Calder
Journal:  N Engl J Med       Date:  1981-11-26       Impact factor: 91.245

9.  Microanatomy of the thymus: its relationship to T cell differentiation.

Authors:  R V Rouse; I L Weissman
Journal:  Ciba Found Symp       Date:  1981

10.  Location of T cell and major histocompatibility complex antigens in the human thymus.

Authors:  A K Bhan; E L Reinherz; S Poppema; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

Review 2.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Intrathymic lymphoid cell differentiation in myasthenia gravis: an immunophenotypic study.

Authors:  M F Ferrio; L Durelli; U Massazza; R Cavallo; G Poccardi; G Maggi; C Casadio; M Di Summa; L Bergamini
Journal:  Ital J Neurol Sci       Date:  1991-12

4.  Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients.

Authors:  L Durelli; G Maggi; C Casadio; R Ferri; S Rendine; L Bergamini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

5.  Intra- and extrathymic B cells in physiologic and pathologic conditions. Immunohistochemical study on normal thymus and lymphofollicular hyperplasia of the thymus.

Authors:  W J Hofmann; F Momburg; P Möller; H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

6.  Thymic hyperplasia. II. Lymphofollicular hyperplasia of the thymus. An immunohistologic study.

Authors:  W J Hofmann; P Möller; H F Otto
Journal:  Klin Wochenschr       Date:  1987-01-15

Review 7.  The Multifaceted Roles of B Cells in the Thymus: From Immune Tolerance to Autoimmunity.

Authors:  Justine Castañeda; Yessia Hidalgo; Daniela Sauma; Mario Rosemblatt; María Rosa Bono; Sarah Núñez
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.